Diaverum acquires two clinics in Brazil, and enters the largest country in Latin America

Diaverum creates a strong presence from the start through the acquisition of the two clinics in Ameng and Clinese. 900 patients will be treated in the clinics and the number is expected to grow. 

SAO PAULO/GOTHENBURG, (January 31st, 2018) - Diaverum, one of the leading renal care providers worldwide, announce the acquisition of two dialysis treatment centres in the States of Sao Paulo and Sergipe, respectively.

With these two acquisitions Diaverum will treat 900 dialysis patients on the Brazilian market and aims to expand further during 2018. Both Ameneg and Clinese have impressive numbers of Peritoneal dialysis (PD) patients, of the 900 patients, 200 are PD patients; 700 are hemodialysis (HD) patients. As a part of the Clinese acquisition, an acute center - Senefro - was acquired in the city of Aracaju. Diaverum will perform more than 13,000 acute treatments per year.

Rafael Romanini has been recruited to the position as Country Managing Director in Brazil. Mr Romanini’s responsibilities will be to lead and continue to grow the business in Brazil and to integrate the newly acquired clinics in northeast Brazil and Sao Paulo.

“Diaverum is looking forward to partnering with the Brazilian healthcare authorities in establishing an integrated patient care set up to optimize the use of healthcare budgets - for the benefit of the patient and the society.” Dag Anderson, CEO of Diaverum.

“Our mission in Brazil is to improve our patients quality of life, and to do so, we are partnering with high standard centres and the best professionals in the market.” Marie Sjodahl, Area Director Latin America, Diaverum.

“Since we are a product-independent company we can guarantee a clear patient focus and based on our global experience we will invest significantly in education and clinical activities to improve patient care and medical outcomes.” Dr. Jörgen Hegbrant, SVP Chief Medical Officer, Diaverum.

Press contact:

Christina Waller Sterner
SVP, Chief Commercial Officer
Diaverum
christina.sterner@diaverum.com
+46 46 287 30 00

 

About Diaverum
Diaverum is a global renal care provider with a clear patient focus. The company stands for first-class healthcare, state-of-the-art education, and patient-centered research aimed at improving quality of life for renal patients. Diaverum’s experience in renal care dates back more than 25 years, when it established its first dialysis clinic in Sweden under the former name Gambro Healthcare. Today, 10,000 employees care for more than 32,000 patients in 20 countries in Europe, Latin America, Middle East, and Australia / New Zealand. Diaverum has its head office in Lund and a corporate office in Gothenburg.

Diaverum established its presence early in the Latin American market and is active in Argentina, Chile, Uruguay and since 2017 in Brazil. The Brazilian market is highly fragmented with more than 725 clinics out of which 60% are independent. There are more than 111,000 patients on dialysis in Brazil today, and the number is likely grow to 200,000 patients in the coming years. This growth is driven by an ageing population, an improved level of education and growing middle class demanding basic healthcare coverage. 

Tags:

About Us

Diaverum is a global renal care provider with a clear patient focus. The company stands for first-class healthcare, state-of-the-art education, and patient-centered research aimed at improving quality of life for renal patients. Diaverum’s experience in renal care dates back more than 25 years, when it established its first dialysis clinic in Sweden under the former name Gambro Healthcare. Today, 10,000 employees care for more than 30,000 patients in 20 countries in Europe, Latin America, Middle East, and Australia / New Zealand. Diaverum has its head office in Lund and a corporate office in Gothenburg. www.diaverum.com

Subscribe